BetterLife Pharma Inc (QB) (BETRF)

$BETRF Indicators Summary - https://www.tradingview.com/symbols/OTC-BETRF/technicals/

$BETRF Chart view

$BETRF BetterLife Pharma: The Neuroplastogen Revolution - Heal the Brain

$BETRF Revolutionizing Brain Health
BetterLife is developing non-hallucinogenic psychedelic derived compounds that can repair, rewire and heal the brain.

The New Paradigm and its Challenges
Psychedelics have emerged as a new paradigm in treatment of neurological and psychiatric disorders. A key property of psychedelics is their neuroplastogenic activity.


A neuroplastogen is a compound that induces new neuronal growth - enabling the brain to rewire, repair and heal itself.
Psychedelics are potent neuroplastogens when given at full doses, but they have several challenges related to their side effects, accessibility and complicated treatment protocols. Firstly, they have unwanted side effects like hallucinations, cardiac damage risks and other side effects. Secondly, being controlled substances, patient self-administration at home is illegal in most countries. Thirdly, treatment is restricted to specialized clinics with monitoring under special treatment protocols which require in-clinic time of 8 to 12 hours in the presence of two mental healthcare professionals.

https://abetterlifepharma.com/our-approach/

$BETRF Chart view

$BETRF #stockscan #stockforecast The BetterLife Pharma Inc (BETRF) stock price forecast for the next 30 days is generally positive, https://stockscan.io/stocks/BETRF

$BETRF OUR LEADERSHIP 🕺
… is focused on developing breakthrough treatments that will repair, rewire and heal the brain. https://abetterlifepharma.com/about-us/

Working together to Build a BetterLife for all. https://abetterlifepharma.com/contact/ #stocktowatch #stockinfocus #dailystocktowatch

$BETRF #BETRF BETTERLIFE PHARMA #OTCQB & #DFTX Definium Therapeutics. #NASDAQ comparison.

$BETRF BetterLife Pharma Inc. is an emerging biotechnology company primarily focused on developing and commercializing BETR-001 to treat various neurological disorders. BETR-001, which is in preclinical and IND-enabling studies, is a non-hallucinogenic and non-controlled LSD derivative in development and it is unique in that it is unregulated and therefore can be self-administered. BetterLife's synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent, for composition and method of use, covers treatment of various neurological disorders, until around 2042.

$BETRF Stock forecast https://stockscan.io/stocks/BETRF

$BETRF Watch 🧠BetterLife Pharma: Revolutionizing Brain Health Through Non-Hallucinogenic Neuroplastogens



BetterLife Pharma is a biotechnology organization dedicated to transforming the landscape of mental health treatment through the development of non-hallucinogenic compounds. Their primary focus is an innovative molecule known as BETR-001, a refined version of LSD designed to offer therapeutic benefits for depression and anxiety without the intense psychedelic side effects. By eliminating the sensory distortions typically associated with these substances, the company aims to provide accessible medicines that patients can safely use at home. This scientific approach addresses the rising societal burden of psychological conditions while navigating fewer regulatory obstacles than traditional illicit drugs. Ultimately, the company strives to provide evidence-based solutions for those suffering from chronic neurological and psychiatric disorders.

#BETRF #otcqb
🧠BetterLife Pharma: Revolutionizing Brain Health Through Non-Hallucinogenic Neuroplastogens

#BetterLife #Pharma is a biotechnology organization dedicated to transforming the landscape of mental health treatment through the development of non-hallucinogenic compounds. Their primary focus is an innovative molecule known as BETR-001, a refined version of LSD designed to offer therapeutic benefits for depression and anxiety without the intense psychedelic side effects. By eliminating the sensory distortions typically associated with these substances, the company aims to provide accessible medicines that patients can safely use at home. This scientific approach addresses the rising societal burden of psychological conditions while navigating fewer regulatory obstacles than traditional illicit drugs. Ultimately, the company strives to provide evidence-based solutions for those suffering from chronic neurological and psychiatric disorders.

First... invest in MNMD... profit on FDA approval of their MM-120 candidate over the next 12 months. Then pour those winning here as BETRF gets IND and P1 of their drug candidate BETR-001....

Thank me later.

Hahaha, same. Down $200 bucks, averaged at .24. No sweat! .07, you say? Alright, count me in. I'll double down with ya :)

Now it's even lower - wild. I'll hold. If it drops below .07 I'm going to load up like a fiend.

Started collecting my bag at .40 Hindsight is 20/20, but I'm loving the price below .20.

2 monster 2000% runs in the last 10 years, as well as 3 smaller 200% runs. I like the pipeline. Price hasn't been this low since 2013. I'll take my chances going long.

I bought some shares of BETRF today. Had the buy limit and it finally hit.

$BETRF / $BETR Emerging Growth Conference 16 Replay Available Now.

Registration link for the NEXT conference and Conference Replay link are here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165966391

$BETRF / $BETR Live on the Emerging Growth Conference in 30 minutes!

The Link to Register to Interact Live with the CEO's is here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165918728

Other Companies Presenting:
$SWISF / $SWIS
$LFAP / $LGBT
$FTXP
$ASCK
$TOMDF
$CYDY

Presented Earlier:
$NSAV
$EGLX
$AVCN / $AVCNF

$BETRF $BETR is presenting on Emerging Growth Conference 16 Today!

The Registration link to interact Live with the CEO is here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165918728

Companies Presenting:
$NSAV
$EGLX
$ILUS
$AVCN
$BETRF / $BETR
$SWISF / $SWIS
$LFAP / $LGBT
$FTXP
$ASCK
$TOMDF
$TPTW - Postponed to 9/29
$CYDY

$BETRF Better Life Pharma. CEO Live on the Emerging Growth Conference on September 15, 2021

Registration link to interact Live here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165842737

Who else would you like to see?
email:
Conference@EmergingGrowth.com
or
Call the number here:
http://EmergingGrowth.com/Conference

I'm trying to get in at .18

I don't think it's a falling knife but who knows? I like psychedelic stocks and they have a bunch of doctors who have names I cannot pronounce = buy!

I'll sell half when it doubles.

$BETRF Replay Emerging Growth 12/ IHub Conference:

Youtube Link and Next Conference Link Here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165086789

$PBIO
$CLNV
$CLIS
$BETRF
$BMIX
$DMAN
$TCFF
$YEG
$WNRS
$GROM

Who do you want to see on the next Conference?
Conference@EmergingGrowth.com

$BETRF CEO Live on the Emerging Growth / Investors Hub Conference in 30 minutes

Registration Link Here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165025662

Other Companies Presenting:
$BMIX
$DMAN
$PIXY
$TCFF
$YEG
$WNRS
$GROM

Currently Presenting:
$CLIS

Presented Previously:
$PBIO
$CLNV

$BETRF Live Today on the Emerging Growth 12 / Investors Hub Virtual Investor Conference

9:00 AM Eastern Time

Registration Link Here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165021499

All of the Companies Presenting:
$PBIO
$CLNV
$CLIS
$BETRF
$BMIX
$DMAN
$PIXY
$TCFF
$YEG
$WNRS
$GROM

$BETRF on the Emerging Growth 12 / Investors Hub Conference
July 21, 2021

Register Here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164975844

Other Companies Presenting:
$CLIS
$BETRF
$BMIX
$DMAN
$PIXY
$TCFF
$YEG
$WNRS
$GROM

Who else would you like to see?

Conference@EmergingGrowth.com
-OR-
Call us at the number here:
https://emerginggrowth.com/conference/

$BETRF BetterLife Pharma Presenting Live on the Emerging Growth Conference on July 21, 2021

Registration Link Here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164911889

BetterLife believes that its inhaled IFN-a2b, AP-003, could lessen the severity and duration of COVID-19 and decrease the need for hospital admissions.
https://apple.news/Ab0L-9NLNTWmeAjGyiaBdJQ

Better Life Pharma is leading the charge against addiction! https://apple.news/AshTKSZCLSOmN4X_xbHf2MA

https://www.globenewswire.com/news-release/2021/01/04/2152745/0/en/BetterLife-Files-Patent-for-the-Treatment-of-MDD-Utilizing-its-Second-Generation-Psychedelic-Derivative-for-2-Bromo-LSD.html

https://theprovince.com/news/local-news/covid-19-b-c-researchers-continue-work-on-treatments-outside-limelight-of-vaccine-developments/wcm/022975c3-d88f-4623-8e7b-221d074161d9

https://www.globenewswire.com/news-release/2020/12/29/2151049/0/en/BetterLife-Pharma-Strengthens-Board-of-Directors.html

https://www.globenewswire.com/news-release/2020/12/23/2149783/0/en/BetterLife-Welcomes-Psychedelic-Industry-Leaders-to-the-Senior-Management-Team.html

This POS stock has no ability to recover.
I don’t think they will ever start those trials.
Looks like insiders are selling.

David.

Did you see the news today?
Hiring PR for $50,000 up front and over $20,000 per month?
That is highway robbery.

David.

Absolutely pathetic. I’m worried that the unveiling of the vaccines will/or have already killed any prospects of this one.

Horrible trading so far.

David

NIA better pump this back up.

Doesn’t look good. Early morning news is usually good.
Probably a financing which would be a stock killer.

David

Any ideas why it’s halted?

Halted.
Guess we find out tomorrow.

David

News out$.
https://www.globenewswire.com/news-release/2020/07/30/2070265/0/en/BetterLife-Pharma-Receives-Approval-from-Altum-Pharmaceuticals-Inc-Shareholders-to-Complete-Merger.html

Agreed.

This is the only interferon nebulizer stock on the American exchanges.
At least that I could find.
Once they announce news about starting trials it should move higher.
I am concerned about the lack of awareness surrounding this stock.
Hope that changes.

David.

Just getting started here. Could easily hit $10-$30/share IMO. Look at ALT

Interesting news.
Recent news from London stock showing benefits from inhaled interferon.
This should help get exposure to Betterlife.
Nice movement last 2 days.
Low float. Low market cap.

David.

BETRF: effective June 26,2020 a one for 10 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Effective June 9,2020 Pivot Pharmaeuticals Inc., PVOTF, will change to Betterlife Pharma Inc., BETRF:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

PVOTF Daily Chart

News - Pivot Pharma enters US CBD market with its proprietary CBD product line
Canada NewsWire

VANCOUVER, Oct. 8, 2019

VANCOUVER, Oct. 8, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT/ OTCQB: PVOTF/ FRA: NPAT) has entered into a contract manufacturing and supply agreement with F&B Cosmetics to manufacture Pivot's differentiated portfolio of CBD based wellness products in the United States

Pivot will enter the US market in Q1 2020 with its differentiated CBD based products using Pivot's patented technologies. Pivot recognizes the importance of creating a market leading brand and Pivot is actively working with Joseph Mimran & Associates to brand and market the Pivot products in North America.

Pivot's ultimate goal is to be a market leader in the emerging phytocannabinoids medical wellness market offering comprehensive science based solutions of preventive and self-care treatment to our customers.

"Pivot's future lies in the successful launch of its differentiated CBD product line using Pivot's patented technologies along with customer acceptance of its superior and proprietary phytocannabinoids products," said Dr. Rinow, CEO of Pivot. "With our team of scientists Pivot is focused on the development of value-added CBD and nutraceutical products. Pivot also embraces the ethical responsibility of offering high quality, premium branded products. Pivot's superior products when combined with the branding created by Joseph Mimran & Associates positions Pivot to create a portfolio of world class phytocannabanoid products in the US, Europe and Canada."

About F&B Cosmetics
F&B Cosmetics is a full service FDA registered, cGMP compliant contract manufacturer of premium products from its 125,000 square feet state of the art facility. Based in Tennessee. F&B is servicing some of the largest cosmetic companies in the world.

About Pivot Pharmaceuticals Inc.
Pivot Pharmaceuticals Inc. is a science-based innovative medical wellness company aspiring to offer high quality preventive and self-care solutions to its customers. Pivot has developed pharmaceutical grade products including CBD, phytocannabinoids and nutraceutical products utilizing proprietary delivery technologies that are unique, patent protected with clear superior benefits to the user such as high absorption, low bioburden and ease of use. Pivot is uniquely positioned to execute on its brand leader strategy in its main markets in Germany, US and Canada.